BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1314113)

  • 21. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells.
    Sternås L; Middleton T; Sugden B
    J Virol; 1990 May; 64(5):2407-10. PubMed ID: 2157896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
    J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal disease of natural killer large granular lymphocytes in Taiwan.
    Chou WC; Chiang IP; Tang JL; Su IJ; Huang SY; Chen YC; Liu MC; Lee FY; Wang CH; Shen MC; Chuang SM; Tien HF
    Br J Haematol; 1998 Dec; 103(4):1124-8. PubMed ID: 9886330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
    Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
    Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
    Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
    Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
    Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Blood; 2006 Apr; 107(7):2928-35. PubMed ID: 16332968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of latent membrane proteins (LMP) of Epstein-Barr virus in malignant lymphomas].
    Herbst H; Dallenbach F; Niedobitek G; Anagnostopoulos I; Hummel M; Finn T; Jautzke G; Müller-Lantzsch N; Stein H
    Verh Dtsch Ges Pathol; 1991; 75():175-8. PubMed ID: 1724825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell receptor (alpha, beta, gamma) gene rearrangements and expression in normal and leukemic large granular lymphocytes/natural killer cells.
    Pelicci PG; Allavena P; Subar M; Rambaldi A; Pirelli A; Di Bello M; Barbui T; Knowles DM; Dalla-Favera R; Mantovani A
    Blood; 1987 Nov; 70(5):1500-8. PubMed ID: 2444290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component.
    Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K
    Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Epstein-Barr virus genome in benign polyclonal proliferative T cells of a young male patient.
    Yoneda N; Tatsumi E; Kawanishi M; Teshigawara K; Masuda S; Yamamura Y; Inui A; Yoshino G; Oimomi M; Baba S
    Blood; 1990 Jul; 76(1):172-7. PubMed ID: 2163693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
    Tai YC; Kim LH; Peh SC
    Pathol Int; 2004 Mar; 54(3):158-66. PubMed ID: 14989738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins.
    Young LS; Finerty S; Brooks L; Scullion F; Rickinson AB; Morgan AJ
    J Virol; 1989 May; 63(5):1967-74. PubMed ID: 2539497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
    Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci MG
    J Virol; 1990 Nov; 64(11):5441-7. PubMed ID: 2170681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large granular lymphocyte proliferation with the natural killer-cell phenotype.
    Chan WC; Gu LB; Masih A; Nicholson J; Vogler WR; Yu G; Nasr S
    Am J Clin Pathol; 1992 Mar; 97(3):353-8. PubMed ID: 1543158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes.
    Zambello R; Loughran TP; Trentin L; Pontisso P; Battistella L; Raimondi R; Facco M; Sancetta R; Agostini C; Pizzolo G
    Leukemia; 1995 Jul; 9(7):1207-11. PubMed ID: 7630196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.
    Costello RT; Sivori S; Mallet F; Sainty D; Arnoulet C; Reviron D; Gastaut JA; Moretta A; Olive D
    Leukemia; 2002 May; 16(5):855-60. PubMed ID: 11986947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus.
    Groux H; Cottrez F; Montpellier C; Quatannens B; Coll J; Stehelin D; Auriault C
    Blood; 1997 Jun; 89(12):4521-30. PubMed ID: 9192776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.